Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study

This publication has 20 references indexed in Scilit:

• The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients
  The American Journal of Medicine, 1997
• PROPHYLAXIS OF CYTOMEGALOVIRUS INFECTION IN LIVER TRANSPLANTATION
  Transplantation, 1997
• Effect of Cytomegalovirus Infection Status on First-Year Mortality Rates among Orthotopic Liver Transplant Recipients
  Annals of Internal Medicine, 1997
• CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTS
  Transplantation, 1996
• Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients
  The Lancet, 1995
• A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR-HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS
  Transplantation, 1994
• High-Dose Acyclovir Compared with Short-Course Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Liver Transplant Recipients
  Annals of Internal Medicine, 1994
• Cytomegalovirus Immune Globulin Prophylaxis in Liver Transplantation
  Annals of Internal Medicine, 1993
• A Randomized Prospective Trial of Acyclovir and Immune Globulin Prophylaxis in Liver Transplant Recipients Receiving OKT3 Therapy
  Archives of Surgery, 1992
• Symptomatic Cytomegalovirus Infection as a Significant Risk Factor for Major Infections After Cardiac Transplantation
  The Journal of Infectious Diseases, 1988